Recognition of respiratory syncytial (RS) virus proteins by human and BALB/C CD4+ lymphocytes
- 1 November 1991
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 35 (3), 165-173
- https://doi.org/10.1002/jmv.1890350305
Abstract
Lymphocyte proliferation assays were used to determine the ability of human and BALB/c T‐ lymphocytes to recognise and respond to in vitro challenge with purified preparations of four res piratory syncytial (RS) virus proteins. Human peripheral blood lymphocytes (PBLs) collected from adult donors as well as primed BALB/c mouse splenocytes each responded specifically to challenge with intact RS virus and preparations of the fusion (F), attachment (G),23 kilodalton (23K), and 34K phospho‐ (P) proteins of the virus. F protein was recognised most frequently by human PBLs, and elicited higher levels of response than equivalent concentrations of the other protein preparations examined. The hu‐ man PBL proliferative responses elicited by in vitro challenge with intact virus antigen as well as with each of the four protein preparations were found to be confined to the CD4+ T‐helper (Th) sub‐population of lymphocytes. However, proliferative responses to intact virus and F protein were found to be accompanied by only modest and inconsistent production of Interleu‐ kin‐2 (IL‐2). Finally, no evidence was obtained to indicate that any of the challenge antigens employed in this study were intrinsically mitogenic, as neither naive human cord blood lymphocytes, nor un‐primed BALB/c mouse splenocytes pro liferated when challenged with intact RS virus or with F, G, 23K, or P protein preparations.Keywords
This publication has 30 references indexed in Scilit:
- Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humansClinical and Experimental Immunology, 1990
- Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV diseaseVaccine, 1989
- Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individualsNature, 1989
- Recognition of Respiratory Syncytial Virus Fusion Protein by Mouse Cytotoxic T Cell Clones and a Human Cytotoxic T Cell LineJournal of General Virology, 1989
- Helper T Cell Recognition of Respiratory Syncytial Virus in MiceJournal of General Virology, 1988
- Cytotoxic T Cell Specificity for Respiratory Syncytial Virus Proteins: Fusion Protein Is an Important Target AntigenJournal of General Virology, 1987
- Characterization of the 10 proteins of human respiratory syncytial virus: Identification of a fourth envelope-associated proteinVirus Research, 1985
- The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescenceJournal of Medical Virology, 1985
- Development of in Vitro Correlates of Cell-Mediated Immunity to Respiratory Syncytial Virus Infection in HumansThe Journal of Infectious Diseases, 1978
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977